Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo

Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo

Tao Liu,1,* Tingting Jia,2,* Xia Yuan,2 Cheng Liu,1 Jian Sun,1 Zhenhua Ni,1 Jian Xu,1 Xuhui Wang,2 Yi Yuan2 1Centralab, 2Department of Pharmacy, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China *These authors contributed equally to...

Full description

Bibliographic Details
Main Authors: Liu T, Jia T, Yuan X, Liu C, Sun J, Ni Z, Xu J, Wang X, Yuan Y
Format: Article
Language:English
Published: Dove Medical Press 2016-05-01
Series:International Journal of Nanomedicine
Subjects:
Polymeric Prodrug
Breast Cancer
Controlled Release
Bufalin
Online Access:https://www.dovepress.com/development-of-octreotide-conjugated-polymeric-prodrug-of-bufalin-for--peer-reviewed-article-IJN

Internet

https://www.dovepress.com/development-of-octreotide-conjugated-polymeric-prodrug-of-bufalin-for--peer-reviewed-article-IJN

Similar Items